Allied Market Research

2025

Latam Radiopharmaceuticals Market

LATAM Radiopharmaceuticals Market, by Type (CONTRAST REAGENTS, NUCLEAR REAGENTS) and, by Application (DIAGNOSTICS, DRUG DISCOVERY DEVELOPMENT, RD): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Diagnostics and Biotech

  • Oct 2025

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (30% Off) $3,075 $2,153
Business User License (30% Off) $4,245 $2,972
Enterprise License (30% Off) $6,270 $4,389
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  LATAM Radiopharmaceuticals Market Report Highlights

Aspects Details
icon_5
By Type
  • CONTRAST REAGENTS
  • NUCLEAR REAGENTS
icon_6
By Application
  • DIAGNOSTICS
  • DRUG DISCOVERY & DEVELOPMENT
  • R&D
icon_7
By Region
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_8
Key Market Players

Arc Evolution Corp., NURIX Pharmaceuticals, Biocad, Jubilant Life Sciences Ltd., Mallinckrodt plc, AUSPEC Pharmaceuticals, Almac Group, Amersham Health, McKesson Corporation, Triad Isotopes

Loading Table Of Content...

*Terms and Conditions Apply

LATAM Radiopharmaceuticals Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com